Rotigotine

Microtubule-associated protein tau (UniProt P10636 also known as Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau) is encoded by the MAPT (also known as TAU, MAPT1, MTBTL) gene (Gene ID 4137) in human. In Alzheimer&#8242s

Immunogen Synthetic peptide directed towards the C terminal region of human TOR1B Application Anti-TOR1B antibody produced in rabbit is suitable for western blotting at a concentration of 0.5&#956g/mL.

An orally bioavailable piperazinylbenzoxazolone compound that acts as a substrate competitive and tight-binding inhibitor of autotaxin activity {IC 50 = 2.8 and 1.

Biochem/physiol Actions CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9). CR8 is a more potent pyridyl analogue of roscovitine (Cat.

Biochem/physiol Actions CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9). CR8 is a more potent pyridyl analogue of roscovitine (Cat.

Lemildipine is a new dihydropyridine calcium entry blocker.In VivoGerbils are treated intraperitoneally with Lemildipine (0.1-3 mg/kg) just after release of the occlusion. Four days after the ischemia, they are fixed by perfusing 10%

Lemildipine is a new dihydropyridine calcium entry blocker.In VivoGerbils are treated intraperitoneally with Lemildipine (0.1-3 mg/kg) just after release of the occlusion. Four days after the ischemia, they are fixed by perfusing 10%

Lemildipine is a new dihydropyridine calcium entry blocker.In VivoGerbils are treated intraperitoneally with Lemildipine (0.1-3 mg/kg) just after release of the occlusion. Four days after the ischemia, they are fixed by perfusing 10%

Lemildipine is a new dihydropyridine calcium entry blocker.In VivoGerbils are treated intraperitoneally with Lemildipine (0.1-3 mg/kg) just after release of the occlusion. Four days after the ischemia, they are fixed by perfusing 10%

Lemildipine is a new dihydropyridine calcium entry blocker.In VivoGerbils are treated intraperitoneally with Lemildipine (0.1-3 mg/kg) just after release of the occlusion. Four days after the ischemia, they are fixed by perfusing 10%

Lemildipine is a new dihydropyridine calcium entry blocker.In VivoGerbils are treated intraperitoneally with Lemildipine (0.1-3 mg/kg) just after release of the occlusion. Four days after the ischemia, they are fixed by perfusing 10%

Amino Acid Sequence Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Gln-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His Biochem/physiol Actions Voltage-gated (Kv1.3) potassium channel